Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 7/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 6/20 | 0.41 |
| ▸ | HTR2C | P28335 | 5/20 | 0.41 |
| ▸ | HTR2B | P41595 | 3/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9951996 | 0.84 | MEP1B (0.36) | CYP1A2HTR2A | |
| SCHEMBL9952029 | 0.83 | TAAR1 (0.46) | TAAR1CYP1A2HTR2AHTR2CHTR2B | |
| Hydrochloric Acid SCHEMBL9952054 | 0.81 | TAAR1 (0.45) | TAAR1CYP1A2HTR2AHTR2CHTR2B | |
| SCHEMBL9952136 | 0.78 | MEP1B (0.39) | CYP1A2 | |
| SCHEMBL9952484 | 0.78 | CYP1A2 (0.46) | TAAR1CYP1A2HTR2AHTR2CHTR2B | |
| SCHEMBL9953809 | 0.77 | SLC2A1 (0.37) | — | |
| SCHEMBL24163032 | 0.76 | HTR2A (0.54) | TAAR1CYP1A2HTR2AHTR2CHTR2B | |
| SCHEMBL5274054 | 0.76 | TAAR1 (0.53) | TAAR1CYP1A2HTR2AHTR2CHTR2B | |
| SCHEMBL9953183 | 0.74 | TAAR1 (0.37) | TAAR1CYP1A2HTR2AHTR2CHTR2B | |
| SCHEMBL26065171 | 0.73 | TAAR1 (0.54) | TAAR1CYP1A2HTR2AHTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2655374-A1 | N-(1-(SUBSTITUTED-PHENYL)ETHYL)-9H-PURIN-6-AMINES AS PI3K INHIBITORS | Incyte Corporation (US) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012135009-A1 | PYRIMIDINE-4,6-DIAMINE DERIVATIVES AS PI3K INHIBITORS | INCYTE CORPORATION (US) | 2012-10-04 | — | — | WO | disclosed |
| WO-2012087881-A1 | N-(1-(SUBSTITUTED-PHENYL)ETHYL)-9H-PURIN-6-AMINES AS PI3K INHIBITORS | INCYTE CORPORATION (US) | 2012-06-28 | — | — | WO | disclosed |